Navigation Links
Hanger Orthopedic Group Welcomes Vinit Asar as Chief Growth Officer
Date:1/12/2009

BETHESDA, Md., Jan. 12 /PRNewswire/ -- Hanger Orthopedic Group, Inc. announced today that Vinit K. Asar has joined the organization as Executive Vice President and Chief Growth Officer, effective immediately. Reporting to Hanger President and Chief Executive Officer Thomas F. Kirk, Asar will have responsibility for leading the identification, development, and execution of new opportunities for Hanger's existing operations, as well as launching new businesses consistent with the company's overall growth strategy.

"We're very pleased to welcome Vinit to Hanger," Kirk said. "His extensive background growing businesses within health services and products aligns very well with Hanger's commitment to strategic growth and disciplined operational diversity."

Joining Hanger from Johnson & Johnson (J&J), Asar brings nearly 20 years of extensive global experience developing new health product and service businesses and growing existing organizations, both organically and through acquisitions. Additionally, Asar has held positions in finance, global product management, sales and marketing, and product development at J&J. Asar holds a BS in Business Administration from Aquinas College in Grand Rapids, MI and an MBA from Lehigh University in Bethlehem, PA.

Hanger Orthopedic Group, Inc., headquartered in Bethesda, Maryland, is the world's premier provider of orthotic and prosthetic patient care services. Hanger is the market leader in the United States, owning and operating 677 patient care centers in 45 states and the District of Columbia, with over 3,500 employees including 1,080 practitioners (as of September 30, 2008). Hanger is organized into four units. The two key operating units are patient care, which consists of nationwide orthotic and prosthetic practice centers, and distribution which consists of distribution centers managing the supply chain of orthotic and prosthetic componentry to Hanger and third party patient care centers. The third is Linkia, which is the first and only provider network management company for the orthotics and prosthetics industry. The fourth unit, Innovative Neurotronics, introduces emerging neuromuscular technologies developed through independent research in a collaborative effort with industry suppliers worldwide. For more information on Innovative Neurotronics, Inc. or the WalkAide(R), visit www.ininc.us. For more information on Hanger, visit www.hanger.com.

This document may contain forward-looking statements relating to the Company's revenues, contracts and operations. The United States Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for certain forward-looking statements. Statements relating to future revenues, contracts and operations in this document reflect the current views of management. However, various risks, uncertainties and contingencies could cause actual results or performance to differ materially from those expressed in, or implied by, these statements, including the Company's ability to enter into and derive benefits from managed care contracts, the demand for the Company's orthotic and prosthetic services and products and the other factors identified in the Company's periodic reports on Form 10-K and Form 10-Q filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934. The Company disclaims any intent or obligation to update publicly these forward-looking statements, whether as a result of new information, future events or otherwise.

    Contacts:  Jennifer Bittner, 904-249-2410, jbittner@hanger.com
               Ken Abod, 301-280-4505, kabod@hanger.com


'/>"/>
SOURCE Hanger Orthopedic Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue
2. Hanger Orthopedic Group, Inc. Announces 2008 Year-End Earnings Release Conference Call
3. Parker College of Chiropractic Education Launches Recruiting Campaign for Career Changers and Potential Students
4. Hanger Orthopedic Group, Inc. Receives Favorable New Code for WalkAide
5. Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008
6. Hanger Orthopedic Group, Inc. Announces Underwritten Public Offering by Shareholder
7. Hanger Orthopedic Group, Inc. Receives Positive Outlook from Moodys Investors Service
8. Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income
9. Hanger Orthopedic Group, Inc. Receives Positive Outlook from Standard & Poors Rating Services
10. Hanger Orthopedic Group, Inc. Announces Second Quarter 2008 Earnings Release Conference Call
11. Hanger Orthopedic Group, Inc. Announces an 11% Sales Increase and a 35% Increase in EPS to $0.23 for the Quarter Ended December 31, 2007, Compared to $0.17 in the Prior Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: